Pancreatic ductal adenocarcinoma (PDAC) presents yet another distinct pattern, with KRAS G12C mutations detected in only 2–3% of cases [13], despite the high (>90%) overall frequency of KRAS mutations in this tumor type [14]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.